▲ Vice Chairman Kwon Hyukjin Presenting IR
‘KOREA LIFE SCIENCE WEEK 2021’ exhibition
and conference
were held at COEX in Samsung-dong, Seoul, for two days from November 3rd
to 4th.
On this day, UNDBIO Co., Ltd. participated
in 'K-BD’s Innovative Pharma-Bio IR 2021 (IPIR 2021)' hosted by the Korea Drug
Research Association and presented IR on the "Biosimilar Insulin
Project." IR explained the characteristics, investment scale, business
strategy, and vision of the technology of insulin development the company owned.
It also explained the plans to produce insulin in Korea and advance overseas.
Related Articles: The Korea Drug Research
Association, R&D-oriented ‘IPIR’ Successfully Ended